Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Incidence of yersinia enterocolitica antibodies in patients with inflammatory joint diseases

  • 16 Accesses

  • 1 Citations

Summary

Agglutinating antibodies against Yersinia enterocolitica serotypes 0:3, 0:8 and, to a minor extent, 0:6 were found in 18 out of 93 patients with inflammatory joint diseases. Patients with undifferentiated arthritis showed the highest prevalence of antibodies against Yersinia enterocolitica. The possibility that serotypes other than 0:3 may be involved in triggering arthritis is discussed.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Maky-Ikola, O., Viljanen, M.K., Tiitinen, S., Toivanen, P., Granfors, K. Antibodies to arthritis-associated microbes in inflammatory joint diseases. Rheumatol Int 1991, 10, 231–234.

  2. 2.

    Toivanen, A., Toivanen, P. Reactive arthritis. CRC, Boca Raton, Fla 1988.

  3. 3.

    Maki-Ikola, O., Lehtinen, K., Granfors, K., Vainionpaa, R., Toivanen, P. Bacterial antibodies in ankylosing spondylitis. Clin Exp Immunol 1991, 84, 472–475.

  4. 4.

    Van Bohemen, C.G., Nabbe, A.J.J.M., Goei H.S., Dekker-Sayes, A.J., Zanen, H.C. Antibodies to Enterobacteriaceae in ankylosing spondylitis. Scand J Rheumatol 1986, 15, 143–147.

  5. 5.

    Toivanen, A., Granfors, K., Lahesmaa-Rantala, R., Leino, R., Stahlberg, T., Vuento, R. Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects. Immunol Rev 1985, 86, 47–70.

  6. 6.

    Chiesa, C., Pacifico, L., Cianfrano, V., Midulla, M. Italian experience with yersiniosis (1978–1985). Microbiol Immunol 1987, 9, 76–88.

  7. 7.

    Martini, A., Fantasia, M., Raballo, A. Yersinia enterocolitica 08 “American strain” isolated in Italy. Microbiologica 1989, 12, 345–347.

  8. 8.

    Winblad, S. Erythema nodosum associated with infection with Yersinia enterocolitica. In: Yersinia enterocolitica, Ed.: Bottone, E.J. Boca Raton, Florida, CRC Press, Inc., 1981, 125–133.

  9. 9.

    Ford, D.K., Henderson, E., Price, G.E., Stein, H.B. Yersinia-related arthritis in the Pacific Northwest. Arthritis Rheum 1977, 20, 1226–1230.

  10. 10.

    Leirisalo, M., Skylv, G., Kousa, M., et al. Follow-up study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 1982, 25, 249–259.

  11. 11.

    Kalliomaki, J.L., Leino, R. Follow-up studies of joint complications in yersiniosis. Acta Med Scand 1979, 205, 521–525.

  12. 12.

    Marsal, L., Winblad, S., Wollheim, F.A. Yersinia enterocolitica arthritis in southern Sweden: a four-year follow-up study. Br Med J 1981, 283, 101–103.

  13. 13.

    Toivanen, A., Lahesmaa-Rantala, R., Meurman, O., Sappinen, O. Antibodies against Yersinia, Campylobacter, Salmonella, and Chlamydia in patients with Behçet's disease. Arthritis Rheum 1987, 30, 1315–1316.

  14. 14.

    Hill, J.L., Yu, D.T.Y. Development of an experimental animal model for reactive arthritis induced by Yersinia enterocolitica infection. Infect Immun 1987, 55, 721–726.

  15. 15.

    Merilahti, R., Soderstrom, K.O., Lahesmaa-Rantala, R., Granfors, K., Toivanen, A. Bacterial antigens in synovial biopsy specimens in yersinia-triggered reactive arthritis. Ann Rheum Dis 1991, 50, 87–90.

  16. 16.

    Monno, R.A., Piancone, A.M., Dicarlantonio, M.E. Interaction between Yersinia enterocolitica and human immune system: studies on bacterial binding and antibacterial activity exerted by human peripheral blood lymphocytes. Microbios Letters 1989, 42, 81–89.

  17. 17.

    Bottone, E.J., Sheehan, D.J. Yersinia enterocolitica: guidelines for serologic diagnosis of human infections. Rev Infec Dis 1983, 5, 898–906.

Download references

Author information

Correspondence to Prof. V. Tamburrino.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tamburrino, V., Monno, R., Valenza, M.A. et al. Incidence of yersinia enterocolitica antibodies in patients with inflammatory joint diseases. Clin Rheumatol 12, 354–356 (1993). https://doi.org/10.1007/BF02231578

Download citation

Key words

  • Yersinia Enterocolitica
  • Antibodies
  • Inflammatory Joint Diseases